Edwards Lifesciences Corp Hits New 1-Year High at $88.11 (EW)
Edwards Lifesciences Corp (NYSE:EW)’s share price reached a new 52-week high during mid-day trading on Friday , Analyst Ratings Network.com reports. The company traded as high as $88.11 and last traded at $88.03, with a volume of 567,481 shares. The stock had previously closed at $85.91.
A number of analysts have recently weighed in on EW shares. Analysts at Zacks reiterated a “neutral” rating on shares of Edwards Lifesciences Corp in a research note on Thursday. They now have a $89.00 price target on the stock. Separately, analysts at JMP Securities upgraded shares of Edwards Lifesciences Corp from a “market perform” rating to an “outperform” rating in a research note on Wednesday, June 11th. They now have a $97.00 price target on the stock. Finally, analysts at CRT Capital raised their price target on shares of Edwards Lifesciences Corp from $87.00 to $90.00 in a research note on Thursday, May 22nd. They now have a “buy” rating on the stock. Six equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. The company has an average rating of “Buy” and an average target price of $83.24.
The stock has a 50-day moving average of $82.72 and a 200-day moving average of $73.79. The company has a market cap of $9.248 billion and a P/E ratio of 31.21.
Edwards Lifesciences Corp (NYSE:EW) last announced its earnings results on Thursday, April 24th. The company reported $0.76 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.69 by $0.07. The company had revenue of $522.40 million for the quarter, compared to the consensus estimate of $523.10 million. During the same quarter in the previous year, the company posted $0.72 earnings per share. The company’s revenue for the quarter was up 5.2% on a year-over-year basis. On average, analysts predict that Edwards Lifesciences Corp will post $3.17 earnings per share for the current fiscal year.
In other Edwards Lifesciences Corp news, CEO Michael A. Mussallem unloaded 29,500 shares of the company’s stock in a transaction that occurred on Tuesday, June 24th. The stock was sold at an average price of $85.38, for a total transaction of $2,518,710.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.
Edwards Lifesciences Corporation (NYSE:EW) is focused on technologies that treat structural heart disease and critically ill patients.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.